Last reviewed · How we verify
NCT03989765: RECON
Reducing Coercion in Norway (RECON)
NA trial testing Programme to reduce involuntary treatment episodes in Compulsion in 900 participants. Completed in 30 September 2022.
30 September 2022
Quick facts
| Lead sponsor | University Hospital, Akershus |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 900 |
| Start date | 25 June 2019 |
| Primary completion | 30 September 2022 |
| Estimated completion | 30 September 2022 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Programme to reduce involuntary treatment episodes
Conditions studied
- Compulsion — all drugs for Compulsion →
Sponsor
University Hospital, Akershus
Who can join
Eligibility, any sex, with Compulsion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is considerable geographical variation in the rates of compulsion in psychiatric services within as well as between countries. Reducing the use of compulsion of patients with severe mental illness is an expressed policy aim, and also a demand from service user organisations. In Norway, municipalities hold responsibility for primary care and are therefore central to the delivery of services to people with severe mental illness. This indicates a potential for intervening at the municipal level to reduce the use of compulsion where it is high. The Reducing Coercion in Norway study (RECON) will, in collaboration with municipalities with high compulsion rates, develop a municipal-level intervention (Stage 1) that will be implemented in a cluster-RCT (Stage 2) to test if it has effect on compulsion rates.pulsion rates.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Between No Help and Coercion: Toward Referral to Involuntary Psychiatric Admission. A Qualitative Interview Study of Stakeholders' Perspectives.
Wormdahl I, Husum TL, Kjus SHH, Rugkåsa J, et al · · 2021 · cited 16× · PMID 34484000 · DOI 10.3389/fpsyt.2021.708175 -
Professionals' perspectives on factors within primary mental health services that can affect pathways to involuntary psychiatric admissions.
Wormdahl I, Husum TL, Rugkåsa J, Rise MB. · · 2020 · cited 13× · PMID 33292378 · DOI 10.1186/s13033-020-00417-z -
The ReCoN intervention: a co-created comprehensive intervention for primary mental health care aiming to prevent involuntary admissions.
Wormdahl I, Hatling T, Husum TL, Kjus SHH, et al · · 2022 · cited 7× · PMID 35854270 · DOI 10.1186/s12913-022-08302-w -
Something Happened with the Way We Work: Evaluating the Implementation of the Reducing Coercion in Norway (ReCoN) Intervention in Primary Mental Health Care.
Husum TL, Wormdahl I, Kjus SHH, Hatling T, et al · · 2024 · cited 1× · PMID 38610208 · DOI 10.3390/healthcare12070786 -
Can primary mental health services impact levels of involuntary admissions? A cluster-RCT of the ReCoN intervention.
Rugkåsa J, Nyttingnes O, Šaltytė Benth J, Husum TL, et al · · 2025 · PMID 40307589 · DOI 10.1007/s00127-025-02914-3
Verify or expand the search:
- PubMed search for NCT03989765
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Akershus trials
Trials by the same sponsor.
- NCT06865027 — The Effect of Arterial Carbon Dioxide Levels on Cerebral Blood Flow and Cerebral Autoregulation in the Steep Trendelenbu · NA · enrolling by invitation
- NCT06721754 — Diabetes Related Foot Ulcers with Negative Pressure Wound Therapy · NA · recruiting
- NCT06731985 — The Follow-up After Shorter Tapes Study. Effectiveness and Safety of Shorter Trans-obturator Tapes. · recruiting
- NCT06576752 — Management of Patients with Heart Failure At Home After Hospital Discharge · NA · recruiting
- NCT06032715 — Brief Intervention for Sleep Medication Misuse Among Elderly · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03989765 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Akershus
- Last refreshed: 5 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03989765.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing